Second Versus First Wave of COVID-19 in Patients with MPN

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2022 Jan 22

PMID 35064223

Authors

Tiziano Barbui

Alessandra Iurlo

Arianna Masciulli

Alessandra Carobbio

Arianna Ghirardi

Greta Carioli

Marta Anna Sobas

Elena Maria Elli

Elisa Rumi

Valerio De Stefano

Francesca Lunghi

Monia Marchetti

Rosa Daffini

Mercedes Gasior Kabat

Beatriz Cuevas

Maria Laura Fox

Marcio Miguel Andrade-Campos

Francesca Palandri

Paola Guglielmelli

Giulia Benevolo

Claire Harrison

Maria Angeles Foncillas

Massimiliano Bonifacio

Alberto Alvarez-Larran

Jean-Jacques Kiladjian

Estefania Bolanos Calderon

Andrea Patriarca

Keina Quiroz Cervantes

Martin Griessammer

Valentin Garcia-Gutierrez

Alberto Marin Sanchez

Elena Magro Mazo

Marco Ruggeri

Juan Carlos Hernandez-Boluda

Santiago Osorio

Gonzalo Carreno-Tarragona

Miguel Sagues Serrano

Rajko Kusec

Begona Navas Elorza

Anna Angona

Blanca Xicoy Cirici

Emma Lopez Abadia

Steffen Koschmieder

Daniele Cattaneo

Cristina Bucelli

Edyta Cichocka

Anna Masternak Kulikowska de Nalecz

Fabrizio Cavalca

Oscar Borsani

Silvia Betti

Lina Benajiba

Marta Bellini

Natalia Curto-Garcia

Alessandro Rambaldi

Alessandro Maria Vannucchi

Affiliations

Soon will be listed here.

Citing Articles

Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.

Palandri F, Elli E, Auteri G, Bonifacio M, Benevolo G, Heidel F Blood Cancer J. 2023; 13(1):65.

PMID: 37137878 PMC: 10155661. DOI: 10.1038/s41408-023-00834-6.

SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms.

Borsani O, Ferretti V, Casetti I, Vanni D, Trotti C, Pietra D Res Pract Thromb Haemost. 2023; 7(2):100122.

PMID: 36999122 PMC: 10015773. DOI: 10.1016/j.rpth.2023.100122.

Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.

Marchetti M, Salmanton-Garcia J, El-Ashwah S, Verga L, Itri F, Racil Z Ther Adv Hematol. 2023; 14:20406207231154706.

PMID: 36923264 PMC: 10009041. DOI: 10.1177/20406207231154706.

Breakthrough infections in MPN-COVID vaccinated patients.

Barbui T, Carobbio A, Ghirardi A, Iurlo A, De Stefano V, Sobas M Blood Cancer J. 2022; 12(11):154.

PMID: 36379921 PMC: 9664028. DOI: 10.1038/s41408-022-00749-8.

Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19.

Rodriguez-Mora S, Corona M, Torres M, Casado-Fernandez G, Garcia-Perez J, Ramos-Martin F J Clin Med. 2022; 11(10).

PMID: 35628927 PMC: 9147947. DOI: 10.3390/jcm11102803.